ASHLEY MORROW: Open Payments
NPI 1871934984 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,486 in 262 payments from 20 companies in 2025. Trend: 2023 $4,133 · 2024 $4,879 · 2025 $5,486
Food & beverage: $5,486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 71 | $1,302 |
| Janssen Biotech, Inc. | 38 | $897 |
| Ardelyx, Inc. | 22 | $606 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 35 | $493 |
| Madrigal Pharmaceuticals | 16 | $490 |
| GENZYME CORPORATION | 10 | $342 |
| Ipsen Biopharmaceuticals, Inc | 13 | $216 |
| Lilly USA, LLC | 9 | $213 |
| Phathom Pharmaceuticals, Inc. | 8 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $167 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, SKYRIZI, DUPIXENT, RINVOQ, XIFAXAN, LINZESS.
Industry payments across AL — which companies pay providers there.
